HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events.

Clinical chemistry

Rosenson RS, Brewer HB, Chapman MJ, Fazio S, Hussain MM, Kontush A, Krauss RM, Otvos JD, Remaley AT, Schaefer EJ. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem. 2011 Mar; 57(3):392-410.

2011

https://researcherprofiles.org/profile/1481131

21266551

Rosenson RS, Brewer HB, Chapman MJ, Fazio S, Hussain MM, Kontush A, Krauss RM, Otvos JD, Remaley AT, Schaefer EJ

Important Dates

SECOND CYCLE NOW CLOSED

CHIC-CFAR Symposium: Wednesday, Sept 25, 2019

Laurence Huang, MD

Clinical Professor

I am a pulmonary and critical care medicine specialist with a research focus on pulmonary diseases affecting individuals with HIV, approached from a unique US and global perspective. I am a clinical-translational researcher with clinical cohorts in San Francisco, CA and in Kampala, Uganda.

Priscilla Hsue, MD

Professor and Chief

Medicine

Professional Experience: Dr. Hsue trained in Internal Medicine in the Molecular Medicine Training Program at UC San Francisco and in Cardiovascular Medicine at UC San Francisco. She served as Chief Cardiology Fellow during this time. She has been on the faculty in the Department of Medicine at San Francisco General Hospital since 2002. She started the HIV Cardiology Clinic since March 2004 at the Positive Health Program at Ward 86, which is one of the first subspeciality clinics of its kind in the nation.

CHIC K12

Search form

You are here

HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events.

Important Dates

Laurence Huang, MD

Priscilla Hsue, MD